Giannoni et al. [81] described how prostate cancer-derived IL-6 secretion stimulated release of MMPs from cancer-associated fibroblasts within TME and this resulted in the promotion of tumor growth and angiogenesis, via EMT and upregulation of stem-cell markers in the tumor cells. Here, IL6 is linked to prostate cancer.